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Symptomatic patients with a low cardiac output and low aortic 
valve gradient have a poor prognosis but are at high risk for aortic 
valve surgery. The outcome of percutaneous balloon aortic valvu-
loplasty in this subgroup of patients is unclear. Therefore, 67 
patients (group l) underwent percutaneous balloon aortic valvu-
loplasty between December I, 1986 and November I, 1987 who 
had a low cardiac index «2.5 liters/min per m2) and a low aortic 
valve gradient (::;:40 mm Hg) before the procedure. The results 
were compared with 200 patients (group 2) who had a low cardiac 
index but not a low aortic valve gradient (>40 mm Hg) before the 
procedure and who had similar baseline presenting symptoms. 
After balloon aortic valvuloplasty, there was a greater decrease 
in aortic valve gradient in patients in group 2 than in patients in 
group 1 (mean ± SD -33.0 ± 16.7 mm Hg and -14.6 ± 6.9 mm 
Hg, respectively; p < 0.001) although there was no significant 
Although immediate results of percutaneous balloon aortic 
valvuloplasty for the treatment of severe. symptomatic 
aortic stenosis are generally favorable (1,2). an increased 
incidence of cardiovascular events has been documented at 
follow-up. Restenosis is a significant problem. approaching 
509c occurrence at 6 to 12 months after the procedure 0-5). 
In addition, mortality continues to be high in patients under-
going this procedure 0.4). Because of these findings, use of 
balloon aortic valvuloplasty has been limited to frail. elderly 
patients with severe. symptomatic aortic stenosis who either 
are not candidates for. or would be at very high risk during, 
an aortic valve operation. 
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difference in improvement in estimated aortic valve area (0.31 ± 
0.21 and 0.31 ± 0.22 cm2, respectively; p = NS). In-hospital 
mortality was 11.9% for patients in group 1 which was not 
significantly different from the 7.5 % mortality for patients in 
group 2. However, the actuarial probability of survival at 12 
months for patients who survived the initial hospitalization was 
46% in group 1 and 64% in group 2 (p < 0.05). Moreover, at 
follow-up (mean 8.8 months) 64% of surviving group 1 patients 
displayed clinical improvement, compared with 70% of surviving 
group 2 patients. 
Although the cumulative ongoing mortality is high after bal-
loon aortic valvuloplasty in patients with a low-output, low-
gradient state, there is a subset of patients who will have sus-
tained, symptomatic improvement. 
(J Am Coil CardioI1991;17:828-33) 
Other subgroups of patients may also benefit from balloon 
aortic valvuloplasty. These include patients who present 
with low output and diminished aortic valve gradient hemo-
dynamics. In the presence of depressed ventricular function, 
an aortic valve operation is a high-risk procedure (6-10). 
especially in patients who are elderly and critically ill (8.9). 
In some patients, the calculated aortic valve area is low. 
largely reflecting primary myocardial impairment; thus, the 
actual severity of the aortic valve obstruction may be less 
than estimated (11). In these patients. an aortic valve oper-
ation may be of less benefit and may be associated with 
increased risk (II). On the other hand. it has been proposed 
that balloon aortic valvuloplasty may provide symptomatic 
relief to these patients at lower risk than would an aortic 
valve operation 0.4). 
The purpose of this study was to determine the outcome 
for patients in the Mansfield Scientific Balloon Aortic Val-
vuloplasty Registry with low output. low gradient aortic 
stenosis who underwent percutaneous balloon aortic valvu-
loplasty. 
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Table 1. Baseline Characteristics of 267 Patients* 
Group 1 Group 2 
Number 67 200 
Male gender (%) 64 40 
Age (yr) 79 ± 8 80 ± 7 
Aortic valve area 0.53 ± 0.17 0.42 ± 0.13 
(cm2) 
Aortic valve gradient 32 ± 7 67 ± 20 
(mmHg) 
Left ventricular 161 ± 31 208 ± 39 
systolic pressure 
(mmHg) 
pt 
<0.001 
NS 
<0.001 
<0.001 
<0.001 
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Figure 1. Distribution of patients in group (Gp) I (gradient 
Left ventricular end- 18 ± \0 
diastolic pressure 
20 ± 14 NS ~40 mm Hg) and group 2 (gradient >40 mm Hg) by New York Heart 
Association (NYHA) functional class. 
(mmHg) 
Cardiac output 
(liters/min) 
Ejection fraction (%) 
Coronary artery 
disease present 
(%) 
2.9 ± 0.8 
36 ± 19 
61 
3.3 ± 0.8 
48 ± 18 
45 
<0.001 
<0.001 
<0.05 
*Group I. aortic valve gradient :540 mm Hg; group 2, gradient >40 mm 
Hg. Data are shown as proportion or as mean value ± SO. tFor difference 
between groups. 
Methods 
Study patients. The Mansfield Scientific Balloon Aortic 
Valvuloplasty Registry comprises 492 patients who under-
went percutaneous balloon aortic valvuloplasty at anyone of 
27 institutions between December I, 1986 and October 30, 
1987. Baseline clinical and hemodynamic profiles of each 
patient were entered prospectively into a computerized data 
base, and the techniques of the procedure and procedural 
complications were noted. Hemodynamic variables (mean 
aortic valve gradient, cardiac output and aortic valve area) 
were assessed before and after the procedure. Patients 
entered in the Registry were required to return to the 
institution where the procedure had been performed for 
clinical assessment of their status at 3 to 6 month intervals. 
The study group consisted of all patients entered into 
the Registry who had a low cardiac index (defined as 
<2.5 liters/min per m2) and a low aortic valve gradient 
(:o:AO mm Hg). A total of 67 patients met these criteria (group 
1). Their mean (±SD) age was 78.0 ± 8.0 years (range, 50 to 
90); 64% of the patients were male and 36% were female. 
Patients' symptoms included dyspnea in 97%, angina in 53% 
and syncope in 23%; 39% were in New York Heart Associ-
ation functional class III, and 45% were in class IV. 
For comparison, a second group of 200 patients (group 2) 
in the Registry were selected who had a low cardiac output 
with definite, severe aortic valve obstruction, as manifested 
by a gradient >40 mm Hg and a cardiac index <2.5 liters/min 
per m2• The baseline characteristics of group 1 and group 2 
are shown in Table I. The presenting severity of symptoms 
(functional class) was similar in group 1 and group 2 (Fig. 1). 
Prevalvuloplasty assessment. Coronary angiography was 
performed in 84% of the patients before the procedure. 
Ejection fraction calculated from radio nuclide angiography 
was available in 69%. Before the procedure, all patients 
underwent complete hemodynamic assessment to determine 
their degree of aortic stenosis and the mean aortic valve 
gradient. Aortic valve area was calculated by the Gorlin 
equation (12). 
Valvuloplasty technique. Percutaneous balloon aortic val-
vuloplasty was performed in all patients with use of a 
variation of the technique described by Cribier et al. (1,2). 
For each procedure, success was defined as a 50% decrease 
in the peak to peak gradient, or a 25% increase in aortic 
valve area. In group I, 54 (81 %) of the 67 patients underwent 
dilation with a single balloon whereas 13 (19%) underwent 
dilation with the dual balloon technique. In group 2, the dual 
balloon technique was used in 67 (34%) of the 200 patients 
(p < 0.05 compared with group I). The largest outer diam-
eter of the balloons in group 1 was >20 mm in 24 patients 
(36%). In group 2 patients, the balloon sizes were similar: the 
largest outer diameter was> 20 mm in 87 patients (44%) (p = 
NS compared with group I). There was no significant 
difference in the resultant aortic valve area or aortic valve 
gradient between the patients who underwent dilation with 
the single balloon or dual balloon technique. 
Complications related to the procedure included arterial 
trauma, ventricular tachycardia, ventricular fibrillation, 
asystole, left ventricular perforation, emergency aortic valve 
replacement, sepsis, cerebrovascular accident, myocardial 
infarction, severe hypotension, acute severe aortic regurgi-
tation and death. 
Follow-up. At each 3 and 6 month follow-up visit, one of 
the principal investigators evaluated the patient's clinical 
status. If the patient was not able to return, clinical status 
was ascertained by telephone calls. 
End points atiol/ow-up included clinical status, mortality 
and interval interventional procedures (aortic valve opera-
tion or repeat balloon aortic valvuloplasty). Follow-up was 
obtained in 99% of patients (mean follow-up duration was 8.8 
months). 
Statistical analysis. Changes in continuous variables be-
tween groups were tested with paired t tests. The differences 
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Table 2. Hemodynamic Results in 267 Patients 
Group I Group 2 p 
Success 48 (72%) 172 (86%) <0.01 
Final aortic valve 0.83 ± 0.27 0.72 ± 0.28 <0.01 
area (cm2) 
Final gradient 17.2 ± 6.4 33.5 ± 13.7 <0.001 
(mmHg) 
Final cardiac output 3.2 ± 0.8 3.7 ± 0.8 <0.001 
(liters/min) 
Change in aortic +0.31 ± 0.21 +0.31 ± 0.22 NS 
valve area (cm2) 
Change in gradient -14.6 ± 6.9 - 33.3 ± 16.7 <0.001 
(mmHg) 
in discrete variables between groups were tested with a 
chi-square test. A Fisher exact test was used to compare the 
incidence of complications. Statistical significance was de-
fined as p < 0.05. 
Results 
Baseline hemodynamic characteristics (Table 1). The 
mean aortic valve gradient and cardiac output were signifi-
cantly lower in group I than in group 2. There was no 
significant difference in left ventricular end-diastolic pres-
sure between the two groups. The ejection fraction was 
significantly lower in group I than in group 2. 
Coronary angiography had been performed in 84% of 
patients. There was a higher incidence of coronary artery 
disease (>50% luminal diameter in one or more major 
vessels) in group I. In both groups, the distribution of 
coronary artery disease was one vessel, 36%: two vessel, 
24%; three vessel, 39%; and left main disease, 6%. Aortic 
root angiography, performed in 55% of patients, to assess 
aortic regurgitation showed no significant difference in se-
verity of aortic regurgitation between group I and group 2 (of 
the patients in both groups who had aortic root angiography, 
28% had no, 62% had mild and 10% had moderate regurgi-
tation) (13). 
Immediate hemodynamic results (Table 2, Fig. 2 and 3). 
The success rate was higher in group 2 (86%) than in group 
Figure 2. Aortic valve (A V) gradient before and after balloon aortic 
valvuloplasty for groups 1 and 2 (mean ± SD). 
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Figure 3. Aortic valve area (A V A) before and after balloon aortic 
valvuloplasty for groups 1 and 2 (mean ± SD). 
I (72%) (p < 0.01). The initial and final gradient and cardiac 
output were lower in group I than in group 2. Similarly, the 
initial and final valve areas were higher in group I than in 
group 2. The total change in gradient was lower in group I 
(p < 0.001), but there was no significant difference in the 
change in valve area between the two groups. 
Complications and mortality (Table 3). Complications re-
lated to the procedure occurred in 15% of patients in group 
I and 19.5% of patients in group 2 (p = NS). The in-hospital 
mortality rate was 11.9% for group I and 7.5% for group 2 
(p = NS). Immediate types of complications and causes of 
death in each group are shown in Table 3. 
Follow-up (Table 4, Fig. 4). A total of28 patients (42%) in 
group I died; 47 patients (23%) in group 2 died in the 
foIlow-up period. The later causes of death are shown in 
Table 3. Complications and Immediate Outcome in 267 Patients' 
Group I Group 2 
Outcome No. % No. % 
Complications 
Arrhythmia 4 5.9 10 5.0 
(VTIVF/asystole) 
LV perforation 1.5 3 1.5 
Emergency A VR 0 0 3 1.5 
Myocardial infarction I 1.5 0 0 
Acute severe AR 0 0 1.5 
Severe hypotension I 1.5 9 4.5 
Neurologic 2 3.0 4 2.0 
Arterial 4.5 18 9.0 
Total patients alfectedt 10 15 39 19.5 
In-hospital mortality 
Hemodynamic compromise 3 4.5 5 2.5 
Arrhythmia 2 3.0 5 2.5 
Myocardial infarction 0 0 I 0.5 
Sudden death 1.5 0 0 
Severe AR 0 0 1 0.5 
Tamponade 0 0 2 1.0 
Other (sepsis. ARDS. ARF) 2 3.0 0.5 
Total 8 11.9 15 7.5 
'No difference between groups was statistically significant. tSome pa-
tients had more than one complication. AR = aortic regurgitation; ARDS = 
adult respiratory distress syndrome: ARF = acute renal failure; AVR = aortic 
valve replacement: LV = left ventricle: VTIVF = ventricular tachycardia! 
fibrillation. 
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Table 4. Later Mortality (mean follow-up 3.8 months) 
Group I Group 2 
Cause No. % No. % 
Congestive heart failure 12 18 21 10 
Sudden death 6 8.9 9 4.5 
Myocardial infarction I 1.5 2 1.0 
Sequela of aortic valve 0 0 2 1.0 
replacement 
Noncardiac 6 8.9 9 4.5 
Unknown 3 4.5 4 2.0 
Total 28 42 47 23 
Table 4. The mean time to death was 3.8 months in both 
groups. The actuarial probability of survival at 12 months in 
patients who survived the initial hospital period and did not 
undergo emergency aortic valve replacement was 46% in 
group I and 64% in group 2 (p < 0.05) (Fig. 4). 
Repeat balloon aortic valvuloplasty was performed in 5 
patients (7%) in group I and in 13 patients (7%) in group 2 at 
a mean interval of7.5 and 8.5 months, respectively, after the 
initial procedure because of restenosis and recurrent symp-
toms. Two patients in group I and 17 patients in group 2 had 
aortic valve replacement in the follow-up period. In group I. 
one patient underwent aortic valve replacement because of 
recurrent symptoms; the other patient in the group had the 
procedure because of an improvement in clinical status that 
was thought to lessen the risk of operative mortality. The 12 
month actuarial survival free of all events (death, aortic 
valve replacement or repeat balloon aortic valvuloplasty) 
was 39% in group 1 and 49% in group 2. 
Of the surviving patients, follow-up was available for {/ 
mean duration of 8.8 months. Improvement by at least one 
functional class was found in 64% of patients in group I and 
70% of patients in group 2 (p = NS). For the patients 
surviving to follow-up, 71 % of patients in group I and 69% of 
patients in group 2 were in functional Heart Association 
class I or II (p = NS). 
Figure 4. Actuarial probability of survival at 12 months in patients 
who survived initial hospital period and did not have emergency 
aortic valve replacement. Numbers of patients are in parentheses. 
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Subgroup analysis of group 1 patients. Of the total of 67 
patients in group I (low output, low gradient hemodynam-
ics), 21% were alive and clinically improved at follow-up 
whereas 79% were either dead or not improved. To deter-
mine if there were any predictors of outcome in these group 
1 patients. an analysis of baseline clinical and hemodynamic 
variables was performed. 
There was no significant difference in any of the baseline 
clinical or hemodynamic variables between the patients who 
were alive and clinically improved and those who were not. 
The clinical variables analyzed included age, gender, func-
tional class. presence of syncope, presence of angina and 
presence of coronary artery disease. The hemodynamic 
variables analyzed included aortic valve area, aortic valve 
gradient and cardiac output (before the procedure. after the 
procedure, absolute change); systolic blood pressure, left 
ventricular systolic pressure, and ejection fraction. At 
follow-up, no difference was detected in the use of single-
versus dual balloon technique in the patients who did well 
and those who did not. 
Discussion 
Percutaneous balloon aortic valvuloplasty should be used 
as a palliative procedure in selected patients who are not 
candidates for or who would be at high risk during an aortic 
valve operation (3,4,14). It therefore is imperative to know 
the risks and outcome for balloon aortic valvuloplasty in 
these high risk patients groups. In the subset of patients with 
a low output, low gradient hemodynamic state undergoing 
balloon aortic valvuloplasty, there was no significant differ-
ence in the incidence of complications related to the proce-
dure compared with that of a group of patients with a higher 
aortic valve gradient. The in-hospital mortality in patients 
with low output and low gradient state was 11.9%, which 
was not significantly different from the patients (7.5%) with 
a higher aortic valve gradient who did not survive. 
This in-hospital mortality rate is probably less than would 
be expected for an aortic valve operation in patients of 
similar age and circumstances. Aortic valve operations in 
young, healthy patients can be performed with a risk of <5% 
(10); the risk increases to > 15% from age 2::60 (9) to >70 
years (10), with a 30% 30 day mortality rate in octogenarians 
(15). The mean age of the patients in our study was 78 years. 
The presence of a low cardiac index and depressed ejection 
fraction (a low cardiac index was present in all patients in 
this analysis) greatly increases the mortality risk (6,10). 
There was a high continued mortality rate at 6 month 
follow-up that was highest in the patients with the low 
output, low gradient state. Despite the high initial mortality 
rate, among the patients who survived there was sustained 
symptomatic improvement in nearly two-thirds of patients in 
the groups with a low or a high gradient. Without any 
intervention, one would expect progression of symptoms, 
requiring ongoing intervening medical care (16). 
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Low output, low gradient states. The pathologic abnor-
mality in the majority of elderly patients presenting with 
severe aortic stenosis is senile degenerative calcific disease 
(17). Deposits of calcium at the base of the aortic valve cusps 
cause decreased valve mobility and subsequent obstruction 
to outflow. Because there may be little or no commissural 
fusion, the degree of valve opening is dependent on the flow 
through the valve. The aortic valve area decreases with low 
flow (18,19). Therefore, in the presence of depressed ven-
tricular function and low cardiac output, a low valve area 
may be calculated even when the aortic valve is not severely 
stenotic. 
In severe aortic stenosis, the left ventricle compensates 
for the chronic pressure overload by hypertrophy, in an 
attempt to normalize wall stress so that adequate systolic 
pump function is maintained (8,20). The ejection fraction and 
cardiac output are maintained initially by the Frank-Starling 
mechanism when wall stress begins to increase (8,20), but at 
some point the excess wall stress overwhelms the compen-
sating mechanisms so that left ventricular function dimin-
ishes (21,22). When the decreased ventricular function in 
aortic stenosis is due to this "afterload mismatch" 
(11,21,22), aortic valve replacement results in reversal of left 
ventricular dysfunction and clinical improvement (8,23). 
When there is a primary myocardial process and aortic 
stenosis is less severe, operative mortality becomes much 
higher and the results are suboptimal (11). It has been 
proposed (11) that the magnitude of the gradient and the 
relationship of wall stress to ejection fraction may be of 
benefit in evaluating these two groups. In patients with a 
higher aortic valve gradient, severe aortic stenosis is the 
most likely major pathophysiologic process. However, it is 
still difficult to distinguish between a primary valvular pro-
cess and myocardial disease when the gradient is low. In this 
study, no clinical or hemodynamic baseline variables were 
found that could predict outcome in patients with low 
output, low gradient hemodynamics. 
In patients with low output, low gradient hemodynamics, 
balloon aortic valvuloplasty should not be looked on as a 
curative procedure for the valve but rather as a way to 
change the loading conditions on the poorly functioning left 
ventricle (14). This applies both to the patient with a primary 
valvular process and to the patient with a primary myocar-
dial disease. By decreasing the aortic valve gradient. the 
afterload conditions of the left ventricle may be altered. In 
patients with primary myocardial disease, balloon aortic 
valvuloplasty would act as a mechanical means for afterload 
reduction to provide significant relief of symptoms. Al-
though not specifically studied, it is suspected that patients 
who have low output, low gradient hemodynamics due to 
severe end-stage aortic stenosis may show reversal of left 
ventricular dysfunction after balloon aortic valvuloplasty 
(24). 
Limitations. As in any registry study, this study has a 
population bias, and the results presented here cannot nec-
essarily be extrapolated to all patients with low output, low 
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gradient states. In the participating centers, balloon aortic 
valvuloplasty was reserved for the elderly patients who were 
not surgical candidates and thus represented a critically ill 
group of patients. 
The follow-up on these patients was based only on 
clinical status. The majority of these patients could not 
undergo repeat cardiac catheterization. Nonetheless, the 
clinical data obtained are relevant to clinical application 
because the goal of therapy is to provide symptomatic relief, 
irrespective of changes occurring in the hemodynamic prop-
erties. 
Conclusions. Balloon aortic valvuloplasty can be per-
formed in patients with a low gradient, low output state, 
resulting in in-hospital mortality and morbidity similar to 
those in patients with a higher gradient. Mortality is proba-
bly less than would be expected for a comparable group 
undergoing aortic valve operation. Although there is a high 
mortality rate over short-term follow-up, some patients 
continue to have sustained symptomatic improvement. 
Therefore, balloon aortic valvuloplasty can be looked on as 
a palliative approach for the elderly. critically ill, sympto-
matic patient with severe aortic stenosis and a low output, 
low gradient state. 
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